SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (976)9/8/1998 12:15:00 PM
From: VLAD  Read Replies (2) of 1016
 
Dale,

Perhaps I am guilty of "falling in love" with a stock (My interpretation of believing in a small biotech companies ability to generate some significant profits and I still stand by it).

However you are guilty of the opposite ie "falling in hate" with a stock.

The part I find difficult to grasp is that as a health professional you should be glad that MUSE is available as another alternative to treating a rather complex disorder.

Nobody on the long thread argues that MUSE is perfect, cheap or less invassive than popping a pill and this has not been the premise of believing in the products place in the ED market.

IMO your tough slant against Vivus is mostly inspired by your own laziness in having to spend some time with a patient in explaining the use of a technique oriented therapy. Thus you are so fond of Pfizer and Viagra--it makes your life easier to simply write a script.

Too bad you don't focus on fullfilling your patient's needs and concerns vs your own.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News